Fig. 12From: IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancerExpression of IGF2BP3 in different clinical stage of bladder cancer tissues and normal bladder tissues. A-E Expression of IGF2BP3 in paraffin-embedded tissue sections of normal bladder tissues (n = 27), stage I bladder cancer tissues (n = 20), stage II bladder cancer tissues (n = 22), stage III bladder cancer tissues (n = 22), and stage IV bladder cancer tissues (n = 31) was analyzed with immunohistochemistry. F Quantification of the average optical density (AOD) for IGF2BP3 in normal bladder tissue and different clinical stages of bladder cancerBack to article page